Dr. Evelin Lara, MD, M.S, PhD student, is a physician at IVI Barcelona, were she serves as the Director of the Egg Donation Unit. She received her medical degree with high honors at the Institute of Medical Sciences, University of Havana, and completed her residency training in Internal Medicine at Hermanos Ameijeiras Hospital in Havana, in Cuba.
As the Hermanos Ameijeiras Hospital, she worked as Internal Medicine Consultant in the Diabetes Service, preventing, evaluating and treating complications of Diabetes, and in Transplant Service preparing patients on the waiting list, providing follow-up after transplantation, and performing emergency procedures. In the meantime, she obtained a teaching degree from the Havana University and attended conferences and postgraduate courses on Endocrinology, Virology, and Hepatology.
Dr. Lara’s move to Spain started with a grant award for Medical Training in Organ and Tissue Donation and Transplantation. She worked at the Transplant Coordination Unit in Hospital Clinic of Barcelona, where she obtained her Expertise in Cell, Tissue and Organ Procurement Management. She also worked as coordinator of Research Projects in the Clinic Foundation for Biomedical Research, and was responsible for the Isolation of Liver Cells for Transplantation, in a project by Cytonet GmbH & Co. KG. Weinheim, Germany.
Dr. Lara obtained her M.Sc. in Human Reproduction from the University Rey Juan Carlos of Madrid, Spain, and started working as an attending physician and director of the Egg Donation Unit in IVI Barcelona. As an active member of the European Society of Human Reproduction (ESHRE), and because of her advanced knowledge on screening, diagnosis and treatment of viral diseases, she works in the “Management of assisted reproduction techniques in patients with viral disease” guideline group. She is also member of the American Society of Reproductive Medicine (ASRM) and the Spanish Fertility Society (SEF).
Dr. Lara is currently continuing her postgraduate studies to obtain a Ph.D. from University of Valencia, and leading a multi-center research project in IVI RMA Global. Her research interests include Ovarian Aging, Infectious disease in ART, Gametes donation, and application of Transcriptomics to understand ovarian physiology.
|B.Sc.||Institute Specialized in Exact Sciences Humboldt 7, Havana, Cuba.|
|M.D.||Institute of Medical Sciences, University of Havana, Cuba (1996)|
|Residency||Specialization in Internal Medicine. Hospital «Hermanos Ameijeiras». Havana, Cuba (2000)|
|Fellowship||Organ and Tissue Donation and Transplantation. Hospital Clínic of Barcelona, Transplant Services Foundation. Barcelona, Spain (2006)|
|Fellowship||Advanced International Training in Transplant Coordination, Transplant procurement Management, Barcelona (2006)|
|M.Sc.||Master in Human Reproduction. University Rey Juan Carlos and Valencian Institute of Infertility. Madrid, Spain (2009-2010)|
|Ph.D.||Student University of Valencia (current)|
Honores y reconocimientos
|Medical Training Grant as Assistant in Organ and Tissue Donation and Transplantation. Caroline Foundation and Hospital Clinic of Barcelona||2005|
|Silver Medal Internal Medicine Resident. Hermanos Ameijeiras Hospital||2000|
|Gold Medal to Outstanding Medicine Student. Institute of Medical Sciences, University of Havana, Cuba||1996|
- Future of egg donation.
Text book Egg Bank 1st Edition. Pp 113-116. Editorial Panamericana, 2017.
- Is luteal phase support successfully performed using 25 mg/day of subcutaneous progesterone in controlled ovarian stimulation cycles with GnRH agonist triggering?
Lara EE, Díaz-Gimeno P, Casas AB, Garrigos V, Ballesteros A.
Hum Reprod, 31: i283. 2016.
- Triggering with different doses of gonadotropin releasing hormone (GnRH) agonist in oocyte donor cycles: a randomized clinical trial (RCT).
Pozzobon C, Lara E, Zito G, Lucco F, Garrigos V, Ballesteros A.
Fertil Steril, 100: S60. 2013.
- Donor’s Low Estradiol Levels on the Day of Final Oocyte Maturation: Is there any negative effect on oocyte donation cycles results?
Lara EE, Pozzobon C, Lucco F, Garrigos V, Gonzalez S, Ballesteros A.
Fertil Steril, 96: S254. 2011.
- Pulsatile Renal Perfusion Net M, Machine: Viability Prediction and Improved Preservation of Marginal Kidneys.
Lara EE, Peri Ll, Saval N, Calsamiglia J, Agusti E, Agud A, Ruiz A, Oppenheimer F, Gutierrez R, Alacaraz A, Manyalich M.
Am J Transplant, 7: 197. 2007.
- Pulsatile perfusion kidney preservation improves kidney preservation and provides information about organ viability.
Peri Ll, Net M, Saval N, Lara EE, Agud A, Calsamiglia J, Oppenheimer F, Campistol, Manyalich M, Alcaraz A.
Eur Urol, 6: 93. 2007.
- Gastric Mucormicosis in a diabetic patient with liver transplantation: case report.
Lara EE, Savio AM, Soliva R, González F, Arteaga E.
Rev Cub Med, 45. 2006.
- Hepatic Retransplantation and Acute Budd Chiari Syndrome. Presentation of a case.
Savio AM, Lara EE, Soliva R, Copo J, Gala B, Gonazález F.
Cir Cir, 73: 481-84. 2005.
- Hepatopulmonary syndrome. Presentation of a case and review.
Hernández JC, Samada M, Abreu A, Ramos L, Lara EE, González F.
Rev Cub Med, 44:1-2, 2005.
- Association of postprandial hyperglycaemia and carotid atherosclerotic lesion in patients with type 2 Diabetes Mellitus.
Lara EE, Buchaca E, Valdés M, López C.
Revista Latinoamericana Diabetes, 11: 69-77, 2003.
- Islet Cell antibodies and Insulin autoantibodies in family of first degree of diabetics type 1.
Márquez I, Calderín R, González F, Buchaca E, Fernández F, Rodríguez L, Lara E.
Diabetes Res Clin Pract, 50: 190. 2000.